Aarhus Universitets segl

English

Du er her: AU » Om AU » Organisation » Left atrial appendage occlusion

Om AU

Left atrial appendage occlusion

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review

DOI

  • David R Holmes, Mayo Clinic Rochester, MN
    • ,
  • Kasper Korsholm
  • Josep Rodés-Cabau, Université Laval
    • ,
  • Jacqueline Saw, University of British Columbia
    • ,
  • Sergio Berti, Paediatric Cardiology Unit, Niguarda Hospital, Milan, Italy.
    • ,
  • Mohamad A Alkhouli, Mayo Clinic Rochester, MN

Prevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous revascularisation in patients with carotid disease, device closure for patients with patent foramen ovale, and now, left atrial appendage occlusion (LAAO) for selected patients with non-valvular atrial fibrillation (NVAF). The latter group of patients are the focus of this review which evaluates the pathophysiology, selection of patients, procedural performance, outcomes of treatment both during and post-procedure, adjunctive therapy, complications, and longer-term outcomes.

OriginalsprogEngelsk
TidsskriftEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Vol/bind18
Nummer13
Sider (fra-til)e1038-e1065
ISSN1774-024X
DOI
StatusUdgivet - feb. 2023

Se relationer på Aarhus Universitet Citationsformater

ID: 340325436